Marine sponge aquaculture towards drug development: An ongoing history of technical, ecological, chemical considerations and challenges
Authors:
- Mathilde MaslinMMMathilde Maslin
- Nabila Gaertner-MazouniNGNabila Gaertner-Mazouni
- Cécile DebitusCDCécile Debitus
- Nicole JoyNJNicole Joy
- Raimana HoRHRaimana Ho
Open Access
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Aquaculture Reports
- Vol. 21
Abstract
No abstract availableKeywords
Funding Information
- Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation
This publication has 272 references indexed in Scilit:
- Brominated Skeletal Components of the Marine Demosponges, Aplysina cavernicola and Ianthella basta: Analytical and Biochemical InvestigationsMarine Drugs, 2013
- Functional equivalence and evolutionary convergence in complex communities of microbial sponge symbiontsProceedings of the National Academy of Sciences, 2012
- Bacterial symbionts and natural productsChemical Communications, 2011
- Cell cycle analysis of primary sponge cell culturesIn Vitro Cellular & Developmental Biology - Animal, 2011
- Multiple Approaches To Enhance the Cultivability of Bacteria Associated with the Marine Sponge Haliclona ( gellius ) spApplied and Environmental Microbiology, 2011
- Fungal secondary metabolites – Strategies to activate silent gene clustersFungal Genetics and Biology, 2011
- Deep sequencing reveals exceptional diversity and modes of transmission for bacterial sponge symbiontsEnvironmental Microbiology, 2010
- Design and synthesis of vidarabine prodrugs as antiviral agentsBioorganic & Medicinal Chemistry Letters, 2009
- Seasonal Growth Rate of the Sponge Haliclona oculata (Demospongiae: Haplosclerida)Marine Biotechnology, 2008
- Marine natural productsNatural Product Reports, 2004